Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BASF acetaminophen acquisition

This article was originally published in The Tan Sheet

Executive Summary

BASF Pharma buying bulk acetaminophen production business from Dallas-based Celanese, including the latter company's manufacturing plant in Bishop, Tex. "This acquisition is yet another step by BASF Pharma toward achieving its strategic goal to become a leader in the supply of bulk analgesics," the company says, calling itself a "market leader in the ibuprofen, pseudoephedrine and caffeine businesses." BASF Pharma also makes bulk ephedrine and theophylline. Celanese is the commodity chemicals and acetate products division of Hoechst
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS088886

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel